News from Holden


When he ran out of options, Kent found the kidney cancer treatment he needed in a clinical trial

Tumors that had spread to Kent’s lungs were eliminated by a new immunotherapy offered in a clinical trial at Holden Comprehensive Cancer Center.


Holden Comprehensive Cancer Center opens new infusion suite, expanding cancer care for Iowans

University of Iowa Holden Comprehensive Cancer Center is opening a new infusion suite that will expand access to advanced cancer care for Iowans and patients from across the region.


Radioactive seed localization guides surgeons to exact location of small tumors.

Surgeons and radiologists with Holden Comprehensive Cancer Center are now using a less-invasive tool to localize breast cancers and other abnormalities that may be too small to feel.


Holden is one of three U.S. centers offering the latest radiation therapy technology.

The UI Department of Radiation Oncology this month began using a just-approved radiation therapy device that combines state-of-the-art imaging and radiation targeting. Holden Comprehensive Cancer Center is only the third center in the country offering this technology.


Patients helped design new cellular therapy unit.

The spacious new Stem Cell Transplant and Cellular Therapies Unit was designed with help from patients to make comfort and convenience a top priority,


There’s help for cancer patients to quit smoking.

Holden researchers receive NCI grant to improve smoking cessation interventions for current cancer patients.


Sarcoma outcomes improve at high-volume centers.

Sarcoma patients treated at high-volume medical centers may have higher survival rates than those treated at low-volume centers.


Holden announces CAR T-cell therapy.

Holden is now certified to offer CAR T-cell therapy, a newly approved treatment that uses a patient’s own white blood cells to detect and kill cancer cells.